LAURUSLABS

Laurus Labs, a prominent player in the Pharmaceuticals and Biotechnology sector, has recently achieved a significant milestone by reaching a new 52-week high of Rs. 779.85 on July 8, 2025. This achievement comes as the stock has demonstrated impressive performance, outperforming its sector by 1.1% and gaining 16.17% over the past nine consecutive days. The stock's day began with an intraday low of Rs. 761.05, reflecting a slight dip of 2.01%. However, Laurus Labs continues to trade above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend. In the broader market, the Sensex has shown resilience, climbing 325.48 points to reach 83,712.51 after a flat opening. The index is now just 2.71% away from its own 52-week high. Laurus Labs has outperformed the Sensex over the past year, boasting a remarkable return of 63.73%, compared to the Sensex's 4.69%. With robust financial results, including a 210.5% growth in net profit and high institutional holdings at 37.29%, Laurus Labs continues to solidify its position as a leader in the market.